論文・総説

  • 1997年

    • Yoshimoto, T., Nagase, H., Ishida, T., Inoue J. and Nariuchi, H. 
      Induction of Interleukin-12 p40 transcript by CD40 ligation via activation of Nuclear Factor-κB. 
      Eur. J. Immunol. 27, 3461-3470. (1997)
    • Baba, M., Kikuchi, Y., Mori, S., Kimoto, H., Inui, S., Sakaguchi, N., Inoue, J., Yamamoto, T., Takemori, T., Howard, M. and Takatsu, K. 
      Mouse germinal center B cells with the xid mutation retain responsiveness to anti-mouse CD40 antibodies but diminish IL-5 responsiveness. 
      Int. Immunol. 9, 1463-1373. (1997)
    • Sowa, Y., Shiio, Y., Fujita, T., Matsumoto, T., Okuyama, Y., Kato, D., Inoue, J., Sawada, J., Goto, M., Watanabe, H., Handa, H. and Sakai, T. 
      Retinoblastoma binding factor 1 site in the core promoter of the human Rb gene is activated by hGABP/EFTF1. 
      Cancer Research 57, 3145-3148. (1997)
    • Nishiyama-Fujimoto, A., Ishii, S., Matsuda, S., Inoue, J. and Yamamoto, T. 
      A novel zinc finger proteins Finb is a transcriptional activator and localized in nuclear bodies. 
      Gene 195, 267-275. (1997)
    • Aizawa, S., Nakano, H., Ishida, T., Horie, R., Nagai, M., Yagita H., Okumura, K., Inoue, J. and Watanabe, T.
      TRAF5 and TRAF2 are involved in CD30 mediated NFκB activation. 
      J. Biol. Chem. 272, 2042-2045. (1997)
    • Otsuka, M., Fujita, M., Sugiura, Y., Yamamoto, T., Inoue, J., Maekawa, T. and Ishii, S.
      Synthetic inhibitors of regulatory proteins involved in the signaling pathways of the replication of human immunodeficiency virus 1. 
      Bioorg. Med. Chem.5, 205-215. (1997)
    • Sakamoto, Y., Yoshida, M., Semba, K., and Hunter, T. 
      Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase- mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. 
      Oncogene 15, 2001-2012. (1997)
    • Kuramochi, S., Moriguchi, T., Kuida, K., Endo, J., Semba, K., Nishida, E., and Karasuyama, H. 
      LOK is a novel mouse STE20-like protein kinase that is expressed predominantly in lymphocytes. 
      J Biol Chem. 272, 22679-22684. (1997)
    • Moriyama, M., Yamochi, T., Semba, K., Akiyama, T., and Mori, S. 
      BCL-6 is phosphorylated at multiple sites in its serine- and proline- clustered region by mitogen-activated protein kinase (MAPK) in vivo. 
      Oncogene 14, 2465-2474. (1997)
    • Ojwang, J. O., Mustain, S. D., Marshall, H. B., Rao, T. S., Chaudhary, N., Walker, D. A., Hogan, M. E., Akiyama, T., Revankar, G. R., Peyman, A., Uhlmann, E., and Rando, R. F. 
      Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor α-mediated functions. 
      Biochemistry 36, 6033-6045. (1997)
    • Akiyama, T. and Hogan, M.E. 
      Structural analysis of DNA bending induced by ththered triple helix forming oligonucleotides. 
      Biochemistry 36, 2307-2315. (1997)
    • Ojwang, J. O., Lewis, A. F., Revankar, G. R., Walker, D., Akiyama. T., Hogan, M. E., and Rando, R. F. 
      Sequence-specific inhibition of the tumor necrosis factor-α receptor I gene by oligodeoxynucleotides containing N7 modified 2’-deoxyguanosine. 
      Antisense Nucleic Acid Drug Dev. 7, 447-459. (1997)